Search Count: 81
 |
Sars-Cov-2 3Clpro In Complex With 3-(6-Bromo-2-Hydroxy-3-(Isoquinolin-4-Yl)-4-Oxoquinolin-1(4H)-Yl)Propanenitrile
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN,TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1BY2 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: A1BY2
 |
Sars-Cov-2 3Clpro In Complex With 3-(6-Bromo-2-Hydroxy-3-(Isoquinolin-4-Yl)-4-Oxoquinolin-1(4H)-Yl)Propanenitrile
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN,TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1BY1 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: A1BY1
 |
Sars-Cov-2 3Clpro In Complex With 2-[2-Hydroxy-3-(4-Isoquinolyl)-4-Oxo-6-(Trifluoromethyl)-1H-Quinolin-8-Yl]Benzonitrile
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN,TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1BY3 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: A1BY3
 |
Sars-Cov-2 3Clpro In Complex With 8-(6-Amino-3-Pyridyl)-2-Hydroxy-3-(4-Isoquinolyl)-6-(Trifluoromethyl)-1H-Quinolin-4-One
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN,TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1BY4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: A1BY4
 |
Sars-Cov-2 3Clpro In Complex With 8-(2,5-Dihydro-1H-Pyrrol-3-Yl)-2-Hydroxy-3-(4-Isoquinolyl)-6-(Trifluoromethyl)-1H-Quinolin-4-One
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN,TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1BY5 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: A1BY5
 |
Sars-Cov-2 3Clpro In Complex With 2-Hydroxy-3-(4-Isoquinolyl)-8-(1,2,3,6-Tetrahydropyridin-4-Yl)-6-(Trifluoromethyl)-1H-Quinolin-4-One
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2026-03-18 Classification: VIRAL PROTEIN,HYDROLASE/HYDROLASE INHIBITOR Ligands: A1BY6 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-03-18
Ligands: A1BY6
 |
Structure Of Sars-Cov-2 Nsp14 Bound To N-((4-Vinylthiazol-2-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BX0 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BX0
 |
Structure Of Sars-Cov-2 Nsp14 Bound To N-((4-Cyclopropylthiazol-2-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BXZ |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BXZ
 |
Structure Of Sars-Cov-2 Nsp14 Bound To N-((4-Isopropylthiazol-2-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BX5 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BX5
 |
Structure Of Sars-Cov-2 Nsp14 Bound To 5-(((Cyclopropylmethyl)Amino)Methyl)-N-((4-Cyclopropylthiazol-2-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BYF |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BYF
 |
Sars-Cov-2 Nsp14 Bound To N-((2-Ethynylthiazol-4-Yl)Methyl)-1H-Pyrazole-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BYG |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BYG
 |
Structure Of Sars-Cov-2 Nsp14 Bound To N-((4-Cyclopropylthiazol-2-Yl)Methyl)-1H-Pyrazolo[3,4-B]Pyridine-3-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-12-03 Classification: VIRAL PROTEIN Ligands: ZN, PO4, A1BYT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-03
Ligands: ZN, PO4, A1BYT
 |
Crystal Structure Of Wdr5 In Complex With Triazole-Based Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2025-08-13 Classification: STRUCTURAL PROTEIN/INHIBITOR Ligands: A1BW7 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-08-13
Ligands: A1BW7
 |
Crystal Structure Of Wdr5 In Complex With Triazole-Based Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2025-08-13 Classification: STRUCTURAL PROTEIN/INHIBITOR Ligands: A1BW8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-08-13
Ligands: A1BW8
 |
Crystal Structure Of Wdr5 In Complex With Triazole-Based Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2025-08-13 Classification: STRUCTURAL PROTEIN/INHIBITOR Ligands: A1BW9 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-08-13
Ligands: A1BW9
 |
Human Eaat3 With Compound 3E And Cholesterol Bound At Inward Facing State
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-07-30 Classification: TRANSPORT PROTEIN Ligands: A1CG9, CLR |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2025-07-30
Ligands: A1CG9, CLR
 |
Human Eaat3 With Compound 3E And Digitonin.Glyco-Diosgenin Bound At Inward Facing State
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-07-30 Classification: TRANSPORT PROTEIN Ligands: A1CG9, 9Z9, CLR |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2025-07-30
Ligands: A1CG9, 9Z9, CLR
 |
Human Eaat3 With Sodium Bound At Inward Facing State
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-07-30 Classification: TRANSPORT PROTEIN |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2025-07-30
 |
Cryo-Em Structure Of P2X3 Receptor In Complex With Camlipixant
Organism: Canis lupus
Method: ELECTRON MICROSCOPY Release Date: 2025-03-19 Classification: MEMBRANE PROTEIN Ligands: A1AQX, NAG |
Organism: Canis lupus
Method: ELECTRON MICROSCOPY
Release Date: 2025-03-19
Ligands: A1AQX, NAG
 |
Cryo-Em Structure Of P2X3 Receptor In Complex With Atp:Mg2+
Organism: Canis lupus
Method: ELECTRON MICROSCOPY Release Date: 2025-03-19 Classification: MEMBRANE PROTEIN Ligands: NAG, MG, ATP |
Organism: Canis lupus
Method: ELECTRON MICROSCOPY
Release Date: 2025-03-19
Ligands: NAG, MG, ATP